Ensysce Biosciences, Inc. (ENSC)

CIK 1716947 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Ensysce Biosciences, Inc..

Recent SEC filings

FiledFormAccession number
Nov 4, 20268-K0001493152-26-049906
Oct 30, 2026PRE 14A0001493152-26-049475
Oct 23, 2026S-30001493152-26-048246
Oct 16, 20268-K/A0001493152-26-047317
Sep 29, 20268-K0001493152-26-044802
Aug 25, 20268-K0001493152-26-040080
Aug 24, 20268-K0001493152-26-039898
Aug 20, 2026D0001493152-26-039439
Aug 18, 2026SCHEDULE 13D/A0001493152-26-038943
Aug 18, 202640001493152-26-038866
Aug 13, 20268-K0001493152-26-037794
Aug 13, 202610-Q0001493152-26-037817
Aug 10, 202630001493152-26-036856
Aug 6, 20268-K0001493152-26-036268
Aug 6, 20268-K/A0001493152-26-036326
Jul 15, 20268-K0001493152-26-033360
Jun 26, 2026EFFECT9999999995-26-002133
Jun 4, 2026S-30001493152-26-027289
May 22, 20268-K0001493152-26-025061
May 15, 20268-K0001493152-26-023810
May 15, 202610-Q0001493152-26-023811
Apr 30, 2026S-80001493152-26-020504
Apr 15, 2026EFFECT9999999995-26-001203
Apr 9, 2026S-30001493152-26-015763
Apr 8, 20268-K0001493152-26-015602